Preterm birth (PTB) – birth at fewer than 37 completed weeks of gestation – occurs in approximately 13% of pregnancies and is a major public health problem in the US. Preterm neonates are at greater risk for morbidity and mortality than infants born at term, as a variety of health and developmental complications can arise, including acute respiratory distress syndrome, central nervous system deficits, vision impairments, gastrointestinal problems, and long-term motor and cognitive disabilities. PTB also has considerable emotional and economic impacts on families and causes a significant burden to the health care system.
Significant improvements have been made in treating preterm infants and improving survival. Additional effort should be aimed at reducing the incidence of PTB by focusing on better identification of women at risk for PTB and initiation of effective prevention strategies for women at risk. Effective obstetric nurse care and interventions in these two key areas can help promote maternal-fetal well-being, minimize risk, and enhance patient safety.
Janine Bieda, PhD, MS, CNM, BSN, RN – Program Chair
Perinatology Research Branch/NICHD/NIH/DHHS
Center for Advanced Obstetrical Care and Research
Janine Bieda, PhD, MS, CNM, BSN, RN is a research administrator and coordinator at the Perinatology Research Branch of the National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), of the US Department of Health and Human Services (DHHS), located in Detroit, MI. She is also a manager of the Center for Advanced Obstetrical Care and Research, and an advisory committee member for the Wayne State University Division of Research Institutional Review Board and the American College of Nurse-Midwives Division of Research.
Dr. Bieda obtained her Bachelor of Science in Nursing degree from the University of Michigan in Ann Arbor. She subsequently received her Master’s of Science degree from the University of Michigan Rackham Graduate School, where she also completed her certification in nurse-midwifery.While practicing as a full-scope CNM for Hutzel Hospital at the Detroit Medical Center, she also served as a part-time faculty member for the Wayne State University School of Nursing Nurse-Midwifery and Women’s Health Nurse-Practitioner Programs. She was awarded a National Research Service Award Doctoral Fellowship and completed her Doctor of Philosophy Degree in Women’s Health and Nursing from the University of Michigan. Her doctoral dissertation investigated perceptions of risk for the development of type 2 diabetes in African-American women with gestational diabetes during a current pregnancy. Dr. Bieda is an active member of the American College of Nurse-Midwives and the National Nursing Honor Society, Sigma Theta Tau.
Dr. Bieda’s current role at the Perinatology Research Branch focuses on maternal-fetal medicine research concerning women at risk for preterm birth, as well as other high-risk pregnancy conditions. She recently served as the lead NIH Study Coordinator for an international, multicenter, randomized clinical trial of progesterone for the prevention of preterm birth. Study results demonstrated that the use of vaginal progesterone decreased the rate of preterm birth prior to 33 weeks gestational by 45% and improved neonatal outcomes.
Ray O. Bahado-Singh, MD
Professor and Associate Chairman
Department of Obstetrics and Gynecology
Wayne State University School of Medicine
Director of Obstetric Ultrasound Center for
Fetal Diagnosis and Therapy
Hutzel Women’s Hospital
Ray O. Bahado-Singh, MD, joined the faculty at Wayne State University/Hutzel Women’s Hospital in 2005 and is currently a professor and Associate Chairman of Education for the Department of Obstetrics and Gynecology, a member of the Maternal-Fetal Medicine Division, Director of Obstetric Ultrasound in the Center for Fetal Diagnosis and Therapy, and Acting Director of Perinatal Genetics. Dr. Bahado-Singh is board-certified in maternal fetal medicine and genetics. He has published extensively in the prenatal diagnosis of Down syndrome and other congenital anomalies. He practices clinical high-risk obstetrics, and performs prenatal diagnosis consultations, genetic counseling, obstetrical ultrasounds, fetal echocardiography, amniocentesis, CVS, and other special procedures. Dr. Bahado-Singh’s special interests are first and second trimester screening and prenatal diagnosis using fetal imaging.
This activity is intended for nursing professionals involved in the recognition and management of women at risk for PTB.
This program is designed to address the following IOM competencies: provide patient-centered care and employ evidence-based practice.
At the conclusion of this activity, participants should be able to demonstrate the ability to:
- Explain the clinical burden of PTB and the role of the nurse in PTB management
- Distinguish patients at risk for PTB and initiate screening strategies
- Explain the data linking the impact of the short cervix with PTB
- Recognize the need to employ routine transvaginal ultrasonography to measure cervical length in all pregnant patients
- Assess the risks/benefits of current and emerging interventions
Global Education Group is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Nurses should claim only the credit commensurate with the extent of their participation in the activity.
This educational activity for 1.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commeasurate with the extent of their participation in the activity.
For information about the nursing accreditation of this program, please contact Global at firstname.lastname@example.org or 303-395-1782.
It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty, course directors, program planners/managers, and their spouses/life partners have disclosed relevant financial relationships with commercial companies, and Global Education Group has a process in place to resolve any conflict of interest. Complete disclosures will be provided to program participants at the beginning of the activity and will be included on the program website.
The faculty reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Janine Bieda, PhD, MS, CNM, BSN, RN: Nothing to Disclose
Ray Bahado-Singh, MD: Nothing to Disclose
Non-faculty content contributors and/or reviewers reported the following relevant financial relationships that they or their spouse/partner have with commercial interests:
Global Education Group - Jackie Dawson, MSN, RN: Nothing to Disclose; Amanda Glazar, PhD: (Spouse) Salary - Vitrolife
Rockpointe - Otto Ratz, MD; Bradley Pine, Blair St. Amand; Paula Larson; Jay Katz: Nothing to Disclose
The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.
In order to view this presentation, your computer must have audio capabilities (working speakers or headphones) and must have an Adobe Flash Player. The Adobe Flash Player can be downloaded here.
Instructions for Participants and Obtaining CME Credit
There is no fee for this activity. To receive credit, participants must take the pre-test, view this CME activity in its entirety, and then complete the post-test and evaluation. To complete the evaluation online, choose the best answer to each question. The estimated time for completion of this activity is 1.0 hour. To receive and print their certificates, participants must demonstrate mastery of the presented material via the post-test.
Jointly Sponsored By
|This activity is co-provided by:
Supported by an unrestricted educational grant from Watson Pharmaceuticals, Inc.
By clicking the View/Register Button
you are agreeing that you have read and understood the information on this page.